about
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsCombined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.Characterization of the cell of origin for small cell lung cancerCombined small-cell lung carcinoma: An institutional experienceGenetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience.Prognosis of small cell lung cancer patients with diabetes treated with metformin.Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.Metformin use improves the survival of diabetic combined small-cell lung cancer patients.Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.[Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors].High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.[Clinical Observation of Translating to Small Cell Lung Cancer Following Treatment with EGFR-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma].
P2860
Q26826437-9E16DB42-A53D-4767-8217-2F7AA02B23F5Q28077504-875C61E4-8F53-432D-88CF-CE2FB71B9C68Q34948434-6CD82FFD-4AFB-4C39-9288-A83229D16AB6Q35559970-84BCCB66-B0EB-4142-BA4D-25250FAC20B8Q36439290-F5E3CFD4-1094-4D0B-AF27-318FE77058ECQ37376246-25E61FD5-6684-4EFD-948F-D4F5B7E2BA98Q37636909-05AB4146-AEDC-4FB0-83BE-0194989E0A8DQ40847551-EE6480AD-835A-4BCC-99EB-D0857B367D09Q40909548-A03B9634-B21C-46E2-BE44-BA1670DF4747Q40930334-1B05AC53-41EF-483D-B9E2-EF402F986BCDQ40979412-0A0CF760-8428-4101-82E9-275AC6E01615Q41016802-A46F2E6E-918D-4698-BB29-9782BF139F1DQ41389873-56978FE2-EA7F-451A-9961-6C6BE4156172Q47120303-9B21B566-82EB-49D2-BE37-78E2F3FDE422Q50072136-8CFCBDC8-A966-4243-A6B1-EB2150764D3FQ51606684-6D41FC53-BB3E-486F-BBF6-896DEB161DF4Q51626805-755CCE8A-DE5A-4039-8B85-ED4C79E133D7Q53813022-B475593D-3147-4B24-A421-8D5354398725
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Mixed small cell and non-small cell lung cancer.
@ast
Mixed small cell and non-small cell lung cancer.
@en
Mixed small cell and non-small cell lung cancer.
@nl
type
label
Mixed small cell and non-small cell lung cancer.
@ast
Mixed small cell and non-small cell lung cancer.
@en
Mixed small cell and non-small cell lung cancer.
@nl
prefLabel
Mixed small cell and non-small cell lung cancer.
@ast
Mixed small cell and non-small cell lung cancer.
@en
Mixed small cell and non-small cell lung cancer.
@nl
P2093
P356
P1433
P1476
Mixed small cell and non-small cell lung cancer.
@en
P2093
Adelstein DJ
Horrigan TP
Tomashefski JF Jr
P304
P356
10.1378/CHEST.89.5.699
P407
P577
1986-05-01T00:00:00Z